MMV1802701

ID: ALA5312489

Chembl Id: CHEMBL5312489

Max Phase: Preclinical

Molecular Formula: C27H33N3O3

Molecular Weight: 447.58

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(OC2CCN(C3CCCC3)CC2)c(C(=O)NCc2cccc3[nH]ccc23)c1

Standard InChI:  InChI=1S/C27H33N3O3/c1-32-22-9-10-26(33-21-12-15-30(16-13-21)20-6-2-3-7-20)24(17-22)27(31)29-18-19-5-4-8-25-23(19)11-14-28-25/h4-5,8-11,14,17,20-21,28H,2-3,6-7,12-13,15-16,18H2,1H3,(H,29,31)

Standard InChI Key:  HSHZQTGIZAUUJF-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5312489

    ---

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 447.58Molecular Weight (Monoisotopic): 447.2522AlogP: 4.89#Rotatable Bonds: 7
Polar Surface Area: 66.59Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.66CX Basic pKa: 9.46CX LogP: 3.94CX LogD: 1.88
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.54Np Likeness Score: -0.81

References

1. Bosc N, Felix E, Gardner JMF, Mills J, Timmerman M, Asveld D, Rensen K, Mukherjee P, Das R, Chenu E, Besson D, Burrows JN, Duffy J, Laleu B, Guantai EM, Leach AR..  (2023)  MAIP: An Open-Source Tool to Enrich High-Throughput Screening Output and Identify Novel, Druglike Molecules with Antimalarial Activity.,  14  (12): [PMID:38116432] [10.1021/acsmedchemlett.3c00369]

Source

Source(1):